ADAR1 Capital Management »

Cyclerion Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Cyclerion Therapeutics (CYCN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Cyclerion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclerion Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclerion Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.0M 299k 3.39

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Cyclerion Therapeutics

Kalehua Capital Management
FMR
Balyasny Asset Management
ADAR1 Capital Management
Braidwell
Citadel Advisors
Geode Capital Management
Vanguard Capital Management
Rangeley Capital
Hrt Financial
BlackRock
Dimensional Fund Advisors
Vanguard Fiduciary Trust
UBS Group
Tower Research Capital

View all funds holding Cyclerion Therapeutics